Change in von Willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid fuction after levothyroxine replacement therapy

European Journal of Endocrinology

Volumn 150, Issue 2, 2004, Pages 125-131

  Nagasaki, Toshiki ^a   Inaba, Masaaki ^a   Henmi, Yasuko ^a   Kumeda, Yasuro ^a   Ueda, Misako ^a   Tahara, Hideki ^a   Ishimura, Eiji ^a   Onoda, Naoyoshi ^a   Ishikawa, Tetsuro ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THROMBOMODULIN; THYROID HORMONE; VON WILLEBRAND FACTOR;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; TISSUE INJURY; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; FACTOR VIII; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SERUM; THROMBOMODULIN; THYROXINE; TUNICA INTIMA; TUNICA MEDIA; VON WILLEBRAND FACTOR;

EID: 12144288695     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500125     Document Type: Article

References (39)

1. Kurioka Y, Inaba M, Kawagishi T, Emoto M, Kumeda Y & Nishizawa Y. Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathy. European Journal of Endocrinology 2000 144 1-9.
2. Morikawa Y, Morikawa A & Makino I. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves' disease: TM, a possible new marker of the peripheral activity of thyroid hormones. Journal of Clinical Endocrinology and Metabolism 1993 76 609-614.
3. Takano S, Kimura N, Ohdama S & Aoki N. Plasma thrombomodulin in health and diseases. Blood and Vessel 1990 76 2024-2029.
4. Klein I. Thyroid hormone and the cardiovascular system. American Journal of Medicine 1990 88 631-637.
5. Saito I, Ito K & Saruta T. The effect of age on blood pressure in hyperthyroidism. Journal of the American Geriatrics Society 1985 33 19-22.
6. Inaba M, Henmi Y, Kumeda Y, Ueda M, Nagata M, Emoto M et al. Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients. Biomedicine and Pharmacotherapy 2002 56 241-246.
7. Cuianu M, Nussbaum A, Cristea A, Vladutiu T, Roman S & Stoica D. High levels of plasma von Willebrand factor in hyperthyroidism. Medecine Interne 1987 25 205-210.
8. Muller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ & Marbet GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. European Journal of Clinical Investigation 2001 31 131-137.
9. Soma M, Maeda Y, Matsuura R, Sasaki I, Kasakura S, Saeki Y et al. Study of serum thrombomodulin (TM) levels in patients with hyper- or hypo-thyroidism. Rinsho Byori 1997 45 77-81 [In Japanese].
10. Wren JC. Thyroid function and coronary atherosclerosis. Journal of the American Geriatrics Society 1968 16 696-704.
11. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A & Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Annals of Internal Medicine 2000 132 270-278.
12. Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 2000 10 665-679.
13. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P & Turpin G. Relationship between thyroid hormones and plasma D-dimer levels. Thrombosis and Haemostasis 1998 79 99-103.
14. Giannattasio C, Rivolta MR, Failla M, Mangoni AA, Stella ML & Mancia G. Large and medium sized artery abnormalities in untreated and treated hypothyroidism. European Heart Journal 1997 18 1492-1498.
15. Nagasaki T, Inaba M, Henmi Y, Kumeda Y, Ueda M, Tahara H et al. Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clinical Endocrinology 2003 59 607-612.
16. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y et al. Atherosclerosis in carotid artery of young IDDM monitored by ultrasound high resolution B-mode imaging. Diabetes 1994 43 634-639.
17. Wofford J, Kahl F, Howard G, McKinney W, Toole J & Crouse JI. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arteriosclerosis and Thrombosis 1991 11 1786-1794.
18. Lekakis JP, Papamichael CM, Cimponeriu AT, Stamatelopoulos KS, Papaioannou TG, Kanakakis J et al. Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. American Journal of Cardiology 2000 85 949-952.
19. Simons PC, Algra A, Bots ML, Grobbee DE & van der Graaf Y. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of Arterial disease). Circulation 1999 100 951-957.
20. Kumeda Y, Inaba M, Goto H, Nagata M, Kurioka Y, Furumitsu Y et al. Increased arterial intima-media thickness detected by ultrasonography in patients with rheumatoid arthritis. Arthritis and Rheumatism 2002 46 1489-1497.
21. Hirai T, Sasayama S, Kawasaki T & Yagi S. Stiffness of systemic arteries in patients with myocardial infarction: a noninvasive method to predict severity of coronary atherosclerosis. Circulation 1989 80 78-86.
22. Koshiyama H, Tanaka S & Minamikawa J. Effect of calcium channel blocker amlodipine on the intima-media thickness of carotid arterial wall in type 2 diabetes. Journal of Cardiovascular Pharmacology 1999 33 894-896.
23. Merculi M, Bond G, Sirtori CR, Veglia F, Crepaldi G, Feruglio FS et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The Carotid Atherosclerosis Italian Ultrasound Study. American Journal of Medicine 1996 101 627-634.
24. Migdalis IN, Varvarigos N, Charalabides J, Leontiades E, Gerolimou B, Mantzara F et al. Effects of buflomedil on early carotid atherosclerosis in type 2 diabetic patients. International Angiology 2001 20 126-130.
25. Koshiyama H, Nakamura Y, Tanaka S & Minamikawa J. Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2000 85 2793-2796.
26. Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S et al. Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. Journal of Clinical Endocrinology and Metabolism 1999 84 1329-1333.
27. Dati F, Barthels M, Conrad J, Fluckiger J, Girolami A, Hanseler E et al. Multicenter evaluation of a chromogenic substrate method for photometric determination of prothrombin time. Thrombosis and Haemostasis 1987 58 856-865.
28. Norris CS & Barnes RW. Renal artery flow velocity analysis: a sensitive measure of experimental and clinical renovascular resistance. Journal of Surgical Research 1984 36 230-236.
29. Nacfralane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA & McPherson J. A method for assaying von Willebrand factor (Ristocetin cofactor). Thrombosis et Diathesis Haemorrhagica 1975 34 306-308.
30. Kodama S, Uchijima E, Nagai M, Mikawatani K, Hayashi T & Suzuki K. One-step enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. Clinica Chimica Acta 1990 192 191-200.
31. Ishii H, Uchiyama H & Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thrombosis and Haemostasis 1991 65 618-623.
32. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma without use of preparative ultracentrifuge. Clinical Chemistry 1972 18 499.
33. Christofides ND & Sheehan CD. Enhanced chemiluminescence labeled-antibody immunoassay (Amerlite-MAB) for free thyroxine: design, development, and technical validation. Clinical Chemistry 1995 41 17-23.
34. Kawagishi T, Nishizawa Y, Emoto M, Konishi T, Maekawa K, Hagiwara S et al. Impaired retinal artery blood flow in IDDM patients before clinical manifestations of diabetic retinopathy. Diabetes Care 1995 18 1544-1549.
35. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney International 1995 48 820-826.
36. Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Maekawa K, Emoto M et al. Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetes patients. Circulation 1996 94 704-707.
37. Maeda S, Suzuki S, Moriya T, Suzuki T, Chida M, Suda H et al. Isolated unilateral absence of a pulmonary artery: influence of systemic circulation on alveolar capillary vessels. Pathology International 2001 51 649-653.
38. Hernandez LR, Lundberg U & Arocha-Pinango CL. Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters. Thrombosis Research 2000 99 295-305.
39. Becerra A, Bellido D, Luengo A, Piedrola G & De Luis DA. Lipoprotein(a) and other lipoproteins in hypothyroid patients before and after thyroid replacement therapy. Clinical Nutrition 1999 18 319-322.